Podcast | Radiation Dose Management

A discussion with Nicholas Bevins, Ph.D., vice chair, physics and research, and Jessica Harrington, RCIS. They explain ...

Home June 06, 2019
Home
News | Radiopharmaceuticals and Tracers

BGN Technologies, the technology transfer company of Ben-Gurion University (BGU), introduced a novel method for producing radioisotopes for nuclear medicine and medical imaging technologies such as computed tomography (CT) scan and positron emission tomography-computed tomography (PET-CT).

Home June 05, 2019
Home
News | Computed Tomography (CT)

The Society of Cardiovascular Computed Tomography (SCCT) will present the 2019 Gold Medal Award to Jonathon Leipsic, M.D., FSCCT, and Gilbert Raff, M.D., FSCCT, at the SCCT 14th Annual Scientific Meeting, July 11 – 14 in Baltimore. The SCCT Gold Medal Award recognizes outstanding leaders who have made landmark contributions to the field of cardiovascular computed tomography and to the society.

Home June 05, 2019
Home
News | Hypertension

Orchestra BioMed Inc. announced the presentation of two-year clinical data from the European Moderato I study of BackBeat Cardiac Neuromodulation Therapy (“BackBeat CNT”) for hypertension at the EuroPCR Conference, May 21-24 in Paris, France. Prof. Petr Neužil, M.D., Ph.D., CSc., FESC, head of the department of cardiology of Na Homolce Hospital in Prague, Czech Republic, presented data which showed a strong safety profile of BackBeat CNT and its ability to immediately, substantially and chronically lower blood pressure in patients with persistent hypertension (office BP > 150 mmHg) despite two or more anti-hypertensive medications and an indication for a pacemaker.

Home June 04, 2019
Home
News | Heart Valve Technology

Royal DSM recently announced a collaboration with Strait Access Technologies (SAT), to develop the world’s first durable and cost-effective transcatheter replacement heart valves with polymeric leaflets.

Home June 04, 2019
Home
Technology | Angiography

Medis Medical Imaging Systems B.V. has received clearance from the U.S. Food and Drug Administration for its QAangio XA 3D technology (QFR). The technology offers a non-invasive imaging technique for the assessment of the functional significance of coronary lesions without the need for a pressure wire, nor adenosine.

Home June 04, 2019
Home
News | Congenital Heart

Researchers at University of California San Diego School of Medicine found higher blood pressure and pesticide exposures in children associated with a heightened pesticide spraying period around the Mother’s Day flower harvest. The study, published online in the journal Environmental Research,1 involved boys and girls living near flower crops in Ecuador.

Home June 03, 2019
Home
News | Vascular Access

Terumo Medical Corp. is recalling the SoloPath Balloon Expandable TransFemoral System and Re-Collapsible Balloon Access System due to a potential for the tip to dislodge from the outer rim of the sheath. This may result in a loss of the smooth transition from the surface of the tip to the outer surface of the expandable sheath.

Home May 31, 2019
Home
Podcast | Heart Valve Technology

Marvin Eng, M.D., structural fellowship director at Henry Ford Health System, and William O'Neill, M.D., director of the ...

Home May 31, 2019
Home
Podcast | Structural Heart

A discussion with William O’Neill, M.D., director of the Henry Ford structural heart program, Ruth Fisher, MBA, vice ...

Home May 31, 2019
Home
Iodine-based CT contrast with ready for scanning with a Canon Aquilion One 320-slice CT system at Northwestern Medicine Central DuPage Hospital in the Chicago suburbs. It is not clear that contrast caused contract induced nephrapathy (CIN), also referred to as acute kidney injury (AKI) or contrast-associated acute kidney injury (CAAKI). Photo by Dave Fornell
Feature | Contrast Media | Dave Fornell, Editor

Iodine-based contrast agents used in computed tomography (CT) and catheter-based angiography have been implicated as a ...

Home May 31, 2019
Home
Webinar | CT Angiography (CTA)

This webinar will explain technical considerations when performing cardiac CT angiography in pediatric patients. It ...

Home May 29, 2019
Home
Webinar

Chest pain is one of the most frequent reasons for an evaluation in the emergency room.There are multiple imaging ...

Home May 29, 2019
Home
News | Pharmaceuticals

Amarin Corp. plc announced that its supplemental new drug application (sNDA) for Vascepa (icosapent ethyl) capsules has been accepted for filing and granted Priority Review designation by the U.S. Food and Drug Administration (FDA). The Prescription Drug User Fee Act (PDUFA) goal date assigned by the FDA for this sNDA is Sept. 28, 2019. Because of the Priority Review designation, the timing of this PDUFA date is four months earlier than the anticipated standard ten-month review for applications.

Home May 29, 2019
Home
News | Drug-Eluting Balloons

Philips announced the three-year results from the ILLUMENATE Pivotal trial and the ILLUMENATE European randomized clinical trial (EU RCT). These two trials are part of a series of five trials evaluating the safety and efficacy of Stellarex .035″ low-dose1 drug-coated balloon (DCB) to restore and maintain blood flow in the superficial femoral artery and popliteal arteries of patients with peripheral arterial disease. The results were evaluated compared to treatment with uncoated balloons, the current standard of care.

Home May 29, 2019
Home
Subscribe Now